LABTVSSCTX• 28 Days (Normalized)
LABT vs SCTX (Lakewood-Amedex Biotherapeutics Inc. vs Scribe Therapeutics Inc.)
Showing Closing Date Range from Sep 1 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
LABT Performance $1.78
+%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
SCTX Performance $21.28
-26.62%
Scribe Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin LABT LEADS
+26.62 pts
LABT outperforming by 26.62 percentage points
LABTSCTX
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
LABT SCTX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(18 dates)
| Date | LABT Price | LABT Gain (%) | SCTX Price | SCTX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $- | $21.28 | -26.62% | - | |
| Sep 24, 2026 | $- | $21.61 | -25.48% | - | |
| Sep 23, 2026 | $1.78 | -35.51% | $26.53 | -8.52% | -26.99% |
| Sep 22, 2026 | $1.99 | -27.90% | $28.07 | -3.21% | -24.69% |
| Sep 21, 2026 | $2.05 | -25.72% | $28.05 | -3.28% | -22.44% |
| Sep 18, 2026 | $1.99 | -27.90% | $33.00 | +13.79% | -41.69% |
| Sep 17, 2026 | $1.86 | -32.61% | $32.14 | +10.83% | -43.44% |
| Sep 16, 2026 | $2.09 | -24.28% | $29.10 | +0.34% | -24.62% |
| Sep 15, 2026 | $2.17 | -21.38% | $31.66 | +9.17% | -30.55% |
| Sep 14, 2026 | $2.12 | -23.19% | $29.42 | +1.45% | -24.64% |
| Sep 11, 2026 | $2.22 | -19.57% | $29.74 | +2.55% | -22.12% |
| Sep 10, 2026 | $2.05 | -25.72% | $29.47 | +1.62% | -27.34% |
| Sep 09, 2026 | $2.32 | -15.94% | $29.41 | +1.41% | -17.35% |
| Sep 08, 2026 | $2.18 | -21.01% | $31.34 | +8.07% | -29.08% |
| Sep 04, 2026 | $1.88 | -31.88% | $28.67 | -1.14% | -30.74% |
Page 1 of 2